$RTX — BUY 📊 | 6 MONTHS THESIS

$RTX — BUY 📊 | 6 MONTHS THESIS 🎯 Q1 2026 | Rev $22.1B | EPS $1.78 vs $1.52 🟢 | Margin 12.9% 💡 Consensus had a muted view of Q1 at $1.52, but actual $1.78 shows strong momentum. The gap is that the market may not be pricing in the full extent of future estimate upgrades and the potential for multiple expansion as growth accelerates. Our variant view is that FY2026 EPS will reach $8.00+ vs. 📉 Reward/risk: 1.9:1 🏢 Business Quality: 7/10 - High-quality diversified A&D franchise with wide moat in defense and aerospace, but exposed to commercial cycle and capital intensity. 📊 Valuation: rich on trailing P/E of 27x vs. defense peers at 17-20x, but fair when considering above-peer growth potential; using EV/EBITDA and FCF yield would... 🔮 Catalyst: Analyst EPS estimate upgrades following the Q1 beat and conference call guidance 📊 Our read: BUY. Full analysis → https://stockduty.xyz/s/RTX0618

🎯 Q1 2026 | Rev $22.1B | EPS $1.78 vs $1.52 🟢 | Margin 12.9%